1

FUJIFILM Corporation

FIRM (Forum for Innovative Regenerative Medicine) Head, Steering Committee

Takuya Yokokawa

18nd March, 2016

Welcome to Japan’s Regenerative Medicine Market

2

About FIRM Established on June 17, 2011

To accelerate Industrialization Regenerative Medicine in Japan

Machinery・Device

35

Chemical・Material

45

Regenerative Medicine・Cell Therapy Bio-technology 45 Pharmaceutical

Logistics・Insurance・Consulting etc.

60

FIRM members – 185 companies (January. 2016)

General Meeting

Board of Directors

Auditors

Secretariat

Committees for National/Public

Projects

Supporting Industries Committee

Council for Steering Committee

Steering Committee

Regenerative Medicine Industrialization

Task Force

ISO/TC276

Japan Mirror Committee

Regulatory Committee

Educational Affairs Committee

Ethical & Compliance Committee

International Affairs Committee

Publication Committee

Business & Public Affairs Committee

Medical Economics Committee

Standardization Committee

Regulatory Affairs Committee

Management Committees Expert Committees

Organization of FIRM

4

“Life Innovation Center”(LIC)

4

【Lot】

■Lot size：8,000m

■Landowner：

Kanagawa Prefectural

government

【Building】

■Use：Laboratory

■Structure：

4 floors

above the ground ■Total floor space：

16,000m

2

2

2015.10

2015.12

2015.3

Canada （CCRM 1)）

USA

（ARM 2)）

Australia （Embassy of Australia）

Asia

United Kingdom （BIA ３)）

Sweden （Embassy of Sweden）

Global Network of FIRM

1) CCRM： Center for Commercialization of Regenerative Medicine

2) ARM： Alliance for Regenerative Medicine

3) BIA： BioIndustry Association 5

2016.2

(2016.3)

Industrialization Support Team Business Office @ Downtown Tokyo

RMIT info-tf@firm.or.jp

http://firm.or.jp/en/en_rmit

Entities interested in Regenerative Medicine

industrialization FIRM member companies

Requests, inquiries, etc.

Response & discussion

Discussion with applicable companies

Partnering

Collaboration

Regenerative Medicine Industrialization Task Force (RMIT) FIRM initiative newly established task force for fostering

Regenerative Medicine Development in Japan.

6

Business office

Conclusion

1.Regenerative Medicine Market in Japan is attractive.

2.To maximize opportunity, Japanese industries welcome foreign companies for collaboration in a lot of business sectors.

3.FIRM is a hub of collaboration. Please contact Regenerative Medicine Industrialization Task Force (RMIT) in FIRM.

7

8

info-tf@firm.or.jp

http://www.firm.or.jp/en/en_rmit

Contact to

Regenerative Medicine Industrialization Task Force (RMIT)

Thank you for your attention